NURO - ヌロメトリックス (NeuroMetrix Inc.)

NUROのニュース

   NeuroMetrix, Inc. (NURO) CEO Shai Gozani on Q1 2022 Results - Earnings Call Transcript  2022/04/26 14:58:04 Seeking Alpha
NeuroMetrix, Inc. (NASDAQ:NASDAQ:NURO) Q1 2022 Earnings Conference Call April 26, 2022 08:00 ET Company Participants Thomas Higgins - Senior Vice President and Chief Financial Officer Shai…
   NeuroMetrix GAAP EPS of -$0.14, revenue of $2.3M  2022/04/26 11:11:10 Seeking Alpha
NeuroMetrix press release (NURO): Q1 GAAP EPS of -$0.14.Revenue of $2.3M (+6.5% Y/Y).The gross margin rate was 77.9% in Q1 2022 versus 73.3% in Q1 2021.The Company ended the quarter…
   NeuroMetrix Reports Q1 2022 Financial Results  2022/04/26 11:00:00 ForexTV
WOBURN, Mass., April 26, 2022 (GLOBE NEWSWIRE) — NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended March 31, 2022. The Company’s mission is to reduce the impact of neurological disorders and pain syndromes on individuals and on population health through innovative non-invasive medical devices. Highlights: Q1 2022 revenue of … The post NeuroMetrix Reports Q1 2022 Financial Results appeared first on ForexTV .
   NeuroMetrix, Inc. Announces Date for First Quarter 2022 Financial Results Conference Call  2022/04/19 13:00:00 GlobeNewswire
WOBURN, Mass., April 19, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2022 first quarter financial results before the opening of the market on April 26, 2022. The Company will host a conference call at 8:00 a.m., Eastern Time on April 26, 2022 to discuss its financial results as well as business developments affecting the Company.
   NeuroMetrix''s Quell Neuromodulator Will Be Tested In Long COVID-19 Syndrome  2022/02/24 19:21:22 Benzinga
NeuroMetrix Inc''s (NASDAQ: NURO ) Quell wearable neuromodulation technology will be evaluated for fibromyalgia-like syndrome in individuals with post-acute COVID-19 syndrome (PACS, or "long COVID"). Quell is an advanced, non-invasive neuromodulation technology covered by 22 U.S. utility patents and numerous … Full story available on Benzinga.com
   At 26.4% CAGR, Wearable Medical Devices Market Size is Projected to Reach USD 195.57 billion by 2027  2021/12/07 09:17:00 Intrado Digital Media
Key Companies in Wearable Medical Devices Market are BD , Ypsomed , Fitbit, Inc. , Apple Inc. , Sonova , NeuroMetrix, Inc. , SAMSUNG , Omron Healthcare, Inc. , AiQ Smart Clothing , Koninklijke Philips N.V. , Other Prominent Player Key Companies in Wearable Medical Devices Market are BD , Ypsomed , Fitbit, Inc. , Apple Inc. , Sonova , NeuroMetrix, Inc. , SAMSUNG , Omron Healthcare, Inc. , AiQ Smart Clothing , Koninklijke Philips N.V. , Other Prominent Player
   Short Interest in NeuroMetrix, Inc. (NASDAQ:NURO) Decreases By 92.2%  2021/11/27 17:38:41 Transcript Daily
NeuroMetrix, Inc. (NASDAQ:NURO) was the target of a large decrease in short interest during the month of November. As of November 15th, there was short interest totalling 29,600 shares, a decrease of 92.2% from the October 31st total of 378,600 shares. Based on an average daily trading volume, of 2,920,000 shares, the short-interest ratio is []
   Electrotherapy Devices Market is Showing Strong Position to 2028 with Profiling Global Players: Medtronic, AliMed, Inc., Abbott, Laborie, Inc., Zynex Medical, NeuroMetrix, Inc., DJO Global  2021/11/26 06:34:13 OpenPR
Electrotherapy Devices market report performs thorough analysis of the potential of the market in the present and the future prospects from various angles. The report provides segmentation of the global market on the basis of technology, application, product, and region.
   Global Pain Management Devices Market Report 2021 Featuring NeuroMetrix, Medtronic, Boston Scientific, Zynex Medical, BioElectronics, SPR Therapeutics, BD & Co Abbott, & Nevro  2021/11/18 22:00:00 PR Newswire
DUBLIN, Nov. 18, 2021 /PRNewswire/ -- The "Pain Management Devices Market - Forecasts from 2021 to 2026" report has been added to ResearchAndMarkets.com''s offering. The global pain management devices market is expected to grow at a compound annual growth rate of 11.04% over the forecast
   NeuroMetrix (NASDAQ:NURO) Stock Passes Above Two Hundred Day Moving Average of $7.85  2021/11/12 17:40:57 Dakota Financial News
NeuroMetrix, Inc. (NASDAQ:NURO)s stock price crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $7.85 and traded as high as $8.30. NeuroMetrix shares last traded at $7.99, with a volume of 300,322 shares traded. The firm has a market capitalization of []
   NeuroMetrix reports data from Quell trial for treatment of fibromyalgia; shares up 7%  2021/06/09 12:45:36 Seeking Alpha
   NeuroMetrix Announces That Top-Line Results from a Randomized Controlled Trial of Quell® for Treatment of Fibromyalgia to be Presented at Two Upcoming Pain Medicine Conferences  2021/06/09 12:00:00 Intrado Digital Media
WOBURN, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported that top-line results from a randomized controlled trial of Quell in patients with fibromyalgia will be presented at two upcoming pain medicine conferences.
   NeuroMetrix''s Nerve Stimulator Shows Mixed Outcomes In Fibromyalgia Trial  2021/06/09 11:20:00 Benzinga
NeuroMetrix Inc (NASDAQ: NURO) has reported that top-line results from a randomized controlled trial of Quell for fibromyalgia will be
   NeuroMetrix Inc. Shares Close the Week 22.2% Lower - Weekly Wrap  2021/02/26 22:30:00 Kwhen Finance
NeuroMetrix Inc. shares closed this week 22.2% lower than it did at the end of last week. The stock is currently up 13.9% year-to-date, up 48.8% over the past 12 months, and down 96.9% over the past five years. This week, the Dow Jones Industrial Average fell 1.7%, and the S&P 500 fell 2.5%. Trading Activity Shares traded as high as $4.61 and as low as $3.22 this week.Trading volume this week was 43.5% lower than the 10-day average and 51.6% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price lags the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 394.4% The company's stock price performance over the past 12 months beats the peer average by 177.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   NeuroMetrix Inc. Shares Close the Day 12.7% Higher - Daily Wrap  2021/02/05 22:30:00 Kwhen Finance
NeuroMetrix Inc. shares closed today 12.7% higher than it did at the end of yesterday. The stock is currently up 29.4% year-to-date, up 25.5% over the past 12 months, and down 96.5% over the past five years. Today, the Dow Jones Industrial Average rose 0.8%, and the S&P 500 rose 0.7%. Trading Activity Shares traded as high as $4.70 and as low as $3.75 this week.Shares closed 1e+1% below its 52-week high and 4e+2% above its 52-week low.Trading volume this week was 30.4% lower than the 10-day average and 75.6% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index today, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 1863.8% The company's stock price performance over the past 12 months beats the peer average by 1017.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

calendar